Admissions: None Delistings: Britvic (BVIC.L) has left the Main Market following its takeover by Carlsberg. Potential** Initial Public Offerings: Cardiogeni PLC has announced its intention to IPO on the AQSE Growth Market. The Group’s platform technology is developing a new class of life-saving cellular medicines that enables the creation of unique (living) cells that are engineered with a therapeutic function. The Group’s lead product, CLXR-001, is a patented engineered cellular medicine to tre ....